BNRNasdaqServices-Medical Laboratories
Burning Rock Biotech Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$12.29−0.61 (-4.73%)
Close on Oct 19, 2026
Burning Rock Biotech statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available
Valuation
| Market Cap | CN¥895.30M |
|---|---|
| Enterprise Value | CN¥418.60M |
| PS Ratio | 1.66 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 1.67 |
Enterprise value
| EV / Sales | 0.78 |
|---|
Income (trailing twelve months)
| Revenue | CN¥539.57M |
|---|---|
| Gross Profit | CN¥402.91M |
| Operating Income | -CN¥54.85M |
| Pretax Income | -CN¥53.79M |
| Net Income | -CN¥55.35M |
| EBITDA | -CN¥33.08M |
Margins
| Gross Margin | 74.7% |
|---|---|
| Operating Margin | -10.2% |
| Pretax Margin | -9.97% |
| Profit Margin | -10.3% |
| EBITDA Margin | -6.13% |
| FCF Margin | -6.24% |
Returns
| Return on Equity (ROE) | -9.92% |
|---|---|
| Return on Assets (ROA) | -6.49% |
| Return on Invested Capital (ROIC) | -72.5% |
| Return on Capital Employed (ROCE) | -9.56% |
Growth
| Revenue Growth (YoY) | 4.60% |
|---|---|
| Revenue Growth (3Y CAGR) | -1.42% |
| Revenue Growth (5Y CAGR) | 4.65% |
Balance sheet
| Cash & Short-Term Investments | CN¥478.39M |
|---|---|
| Total Debt | CN¥1.70M |
| Net Cash (Debt) | CN¥476.69M |
| Net Cash Per Share | 4.38 CNY |
| Equity (Book Value) | CN¥535.26M |
| Book Value Per Share | 4.92 CNY |
| Tangible Book Value | CN¥534.98M |
| Working Capital | CN¥491.61M |
Financial position
| Current Ratio | 2.99 |
|---|---|
| Quick Ratio | 2.62 |
| Debt / Equity | 0.00 |
Cash flow (trailing twelve months)
| Operating Cash Flow | -CN¥28.44M |
|---|---|
| Capital Expenditures | -CN¥5.25M |
| Free Cash Flow | -CN¥33.69M |
| FCF Per Share | -0.31 CNY |
Efficiency
| Asset Turnover | 0.63 |
|---|---|
| Inventory Turnover | 2.67 |
| Revenue Per Employee | CN¥808.95K |
| Profits Per Employee | -CN¥82.98K |
| Employee Count | 667 |
Dividends and yields
| Earnings Yield | -6.18% |
|---|---|
| FCF Yield | -3.76% |
Shares
| Shares Outstanding | 108,858,000 |
|---|---|
| Float | 88,180,800 |
| Shares Held by Insiders | 19.0% |
| Shares Held by Institutions | 1.79% |
Taxes
| Income Tax | CN¥1.56M |
|---|
Scores
| Altman Z-Score | -4.22 |
|---|---|
| Piotroski F-Score | 5 |
| Beneish M-Score | -2.51 |
Calculated by StockData from Burning Rock Biotech's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.